Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
- Status
- TERMINATED
- Phase
- PHASE2
Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)
- Status
- COMPLETED
- Phase
- PHASE4
Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY
- Status
- RECRUITING
- Phase
- NA
Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
- Status
- COMPLETED
- Phase
- PHASE3